Brachytherapy treatment simulation of strontium-90 and ruthenium-106 plaques on small size posterior uveal melanoma using MCNPX code
Authors:
- N.A. BarbosaNBN.A. Barbosa
- L.A.R. da RosaLRL.A.R. da Rosa
- A. FacureAFA. Facure
- D. BrazDBD. Braz
- 1 February 2014
- journal article
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 95, 224-226
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Monte Carlo dosimetry for and eye plaque brachytherapy with various seed modelsMedical Physics, 2009
- The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131CsBrachytherapy, 2008
- Dosimetric comparison of106Ru and125I plaques for treatment of shallow (≤5 mm) choroidal melanoma lesionsBritish Journal of Radiology, 2008
- Uveal Melanoma: Epidemiologic AspectsOphthalmology Clinics of North America, 2005
- NCS Report 14: Quality control of sealed beta sources in brachytherapy2004
- The American Brachytherapy Society recommendations for brachytherapy of uveal melanomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomasOphthalmology, 2002
- Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2000